AU7491487A - Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der. - Google Patents

Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.

Info

Publication number
AU7491487A
AU7491487A AU74914/87A AU7491487A AU7491487A AU 7491487 A AU7491487 A AU 7491487A AU 74914/87 A AU74914/87 A AU 74914/87A AU 7491487 A AU7491487 A AU 7491487A AU 7491487 A AU7491487 A AU 7491487A
Authority
AU
Australia
Prior art keywords
diazole
dihydropyridine
thia
benz
oxa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74914/87A
Inventor
Frank Nordt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7491487A publication Critical patent/AU7491487A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU74914/87A 1986-07-01 1987-06-29 Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der. Abandoned AU7491487A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8616047 1986-07-01
GB868616047A GB8616047D0 (en) 1986-07-01 1986-07-01 A 1 4-dihydropyridine derivatives

Publications (1)

Publication Number Publication Date
AU7491487A true AU7491487A (en) 1988-01-07

Family

ID=10600369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74914/87A Abandoned AU7491487A (en) 1986-07-01 1987-06-29 Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.

Country Status (10)

Country Link
JP (1) JPS6322519A (en)
KR (1) KR880001643A (en)
AU (1) AU7491487A (en)
DE (1) DE3720509A1 (en)
DK (1) DK333587A (en)
FR (1) FR2601012A1 (en)
GB (2) GB8616047D0 (en)
IT (1) IT1216830B (en)
SE (1) SE8702697L (en)
ZA (1) ZA874768B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011695A1 (en) * 1990-04-11 1991-10-17 Bayer Ag USE OF N-ALKYLATED 1,4-DIHYDROPYRIDE INDICARBOXIC ACID ESTERS AS DRUGS, NEW COMPOUNDS AND METHOD FOR THEIR PREPARATION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149855C (en) * 1977-06-20 1987-04-21 Sandoz Ag METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES

Also Published As

Publication number Publication date
KR880001643A (en) 1988-04-25
DK333587D0 (en) 1987-06-29
DE3720509A1 (en) 1988-01-28
IT8748101A0 (en) 1987-06-25
IT1216830B (en) 1990-03-14
JPS6322519A (en) 1988-01-30
SE8702697D0 (en) 1987-06-30
ZA874768B (en) 1989-02-22
GB8715219D0 (en) 1987-08-05
SE8702697L (en) 1988-01-02
FR2601012A1 (en) 1988-01-08
GB8616047D0 (en) 1986-08-06
DK333587A (en) 1988-01-02
GB2192132A (en) 1988-01-06

Similar Documents

Publication Publication Date Title
GB8704089D0 (en) Method of treatment
AU2387988A (en) Method of treating skin disorders
AU613355B2 (en) Method for treating skin diseases
EP0444156A4 (en) Method for treating vascular diseases
AU7491487A (en) Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
GB8916394D0 (en) Method of treatment
AU619410B2 (en) Method of treatment using 17 beta-cyclopropylaminoandrostene derivatives
AU5207290A (en) Method of treatment
GB8718025D0 (en) Method of treatment
GB8704090D0 (en) Method of treatment
GB8704088D0 (en) Method of treatment
CS803287A1 (en) Method of 0,0-dimethyl-s-phthalimidomethyldithiophosphate preparation
CS967587A1 (en) Method of 2,6-dialkyl-n-/l-methoxy-2-propyl-aniline preparation
CS490187A1 (en) Method of 2,5-dibutoxy-4-morpholine-benzendiazononium preparation
GB8820939D0 (en) Novel method of treatment
HU896703D0 (en) Process for the preparation of composition for treating cardiac arrhytmia
GB8911258D0 (en) Method of treatment
GB8912934D0 (en) Method of treatment
GB8912935D0 (en) Method of treatment
GB8906429D0 (en) Method of treatment
GB8924155D0 (en) Method of treatment
GB8928896D0 (en) Method of treatment
GB8906426D0 (en) Method of treatment
GB8904258D0 (en) Method of treatment